The methylation state of Intracisternal A Particle (IAP) genes in mouse teratocarcinoma cell lines has been investigated as an approach to study the regulation of the expression of these particles. Treatment of the cells with the methylation inhibitor 5-azacytidine induces the production of the particles in all the cells; the induction is particularly striking in an embryonal carcinoma cell line which is normally devoid of IAPs. The induction is accompanied by decrease in DNA methylation as demonstrated by using the methylation sensitive isoschizomer enzymes MspI and HpaII. Hypomethylation of the IAP genes correlates with accumulation of IAP, specific polyadenylated RNA reinforcing the hypothesis that methylation plays an important role in the control of IAP expression.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1768-322x.1985.tb00337.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Germ cell tumors, cell surface markers, and the early search for human pluripotent stem cells.
Bioessays
December 2024
The Centre for Stem Cell Biology, The School of Biosciences, The University of Sheffield, Western Bank, Sheffield, UK.
Article Synopsis
- Research on teratocarcinomas in laboratory mice paved the way for isolating human pluripotent stem cells (PSCs) through various studies by different teams.
- The author emphasizes their work at the Wistar Institute in the 1980s, where they and colleagues identified one of the first clonal lines of human embryonal carcinoma cells, highlighting important characteristics like cell surface antigen markers.
- The research was a collaborative effort across laboratories and often influenced by unexpected opportunities rather than a planned approach.
Mouse embryos, chimeras, and embryonal carcinoma stem cells-Reflections on the winding road to gene manipulation.
Bioessays
December 2024
Columbia University, New York, New York, USA.
The relationship of embryonal carcinoma (EC) cells, the stem cells of germ cell- or embryo-derived teratocarcinoma tumors, to early embryonic cells came under intense scrutiny in the early 1970s when mouse chimeras were produced between EC cells and embryos. These chimeras raised tantalizing possibilities and high hopes for different areas of research. The normalization of EC cells by the embryo lent validity to their use as in vitro models for embryogenesis and indicated that they might reveal information about the relationship between malignancy and differentiation.
View Article and Find Full Text PDFThe T-locus - inspiration and distraction?
Bioessays
December 2024
Departments of Pediatrics and Surgery, University of Arizona, Tucson, Arizona, USA.
The T/t locus was a major focus of study by mouse geneticists during the 20th century. In the 70s, as the study of cell surface antigens controlling transplantation antigens was taking off, several laboratories hypothesized that alleles of this locus would control cell surface antigens important for embryonic development. One such antigen, the embryonal carcinoma F9 antigen was said to be an example.
View Article and Find Full Text PDFIdentification of tyrosine brominated extracellular matrix proteins in normal and fibrotic lung tissues.
Redox Biol
May 2024
Department of Biochemistry, Institute of Chemistry, University of São Paulo, SP, Brazil. Electronic address:
Peroxidasin (PXDN) is a secreted heme peroxidase that catalyzes the oxidative crosslinking of collagen IV within the extracellular matrix (ECM) via intermediate hypobromous acid (HOBr) synthesis from hydrogen peroxide and bromide, but recent findings have also suggested alternative ECM protein modifications by PXDN, including incorporation of bromide into tyrosine residues. In this work, we sought to identify the major target proteins for tyrosine bromination by HOBr or by PXDN-mediated oxidation in ECM from mouse teratocarcinoma PFHR9 cells. We detected 61 bromotyrosine (BrY)-containing peptides representing 23 proteins in HOBr-modified ECM from PFHR9 cells, among which laminins displayed the most prominent bromotyrosine incorporation.
View Article and Find Full Text PDFThe origins of human pluripotent stem cells: the road from a cancer to regenerative medicine.
In Vitro Cell Dev Biol Anim
May 2024
The Centre for Stem Cell Biology, The School of Biosciences, The University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.
The notion of using pluripotent stem cells (PSCs) as a source of differentiated cell types for replacement of disease or damaged tissues in regenerative medicine is now an active area of research, with approaches to treating eye diseases such as age-related macular degeneration or Parkinson's disease now on the horizon. But the foundations for this research lie in a quite different area of science, namely the role of genetics of cancer. In this review, we trace the evolution of ideas starting with the discovery that strain 129 mice are particularly subject to develop germ cell tumors, through the identification of embryonal carcinoma (EC) cells as the stem cells of the teratocarcinoma manifestation of these tumors, to the recognition of their relationship to pluripotent cells of the early embryo, and eventually their role in the derivation of embryonic stem cells, first from mouse embryos and then from primates including humans.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!